Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum

NCT03308357 · clinicaltrials.gov ↗
UNKNOWN
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Alfred

Collaborators